ArticleOncology letters2018

Blood-based microRNAs as diagnostic biomarkers to discriminate localized prostate cancer from benign prostatic hyperplasia and allow cancer-risk stratification.

Ghada Al-Kafaji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.